AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2014
May 22, 2014
34931_dirs_2014-05-22_58e2b53e-0a8d-499c-98d3-48d90c1fd260.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-05-22
Reporting Person: Pecora Andrew L (Director, Chief Visionary Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-22 | Common Stock, $0.001 par value | A | 446 | $5.94 | Acquired | 269661 | Direct |
Footnotes
F1: Effective August 15, 2013, the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive a portion of his net salary through the issuance to him by the Issuer of shares of the Issuer's common stock, $.001 par value (the "Common Stock") at the then-market price at the time of issuance, under and subject to the terms and conditions of the Issuers' Amended & Restated 2009 Equity Compensation Plan (the "Plan").